JENNIFER LESTER: Open Payments
NPI 1942740428 · CLINTWOOD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 9 payments from 4 companies in 2025. Trend: 2023 $314 · 2024 $234 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Rybelsus, Ozempic, CAPLYTA, FARXIGA, TRELEGY ELLIPTA, Wegovy.
Industry payments across VA — which companies pay providers there.
